Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes

OBJECTIVE: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epitheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Yusuke, Toshida, Hiroshi, Matsuzaki, Yusuke, Matsui, Asaki, Ohta, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872273/
https://www.ncbi.nlm.nih.gov/pubmed/27257394
http://dx.doi.org/10.2147/IMCRJ.S103299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872273/
https://www.ncbi.nlm.nih.gov/pubmed/27257394
http://dx.doi.org/10.2147/IMCRJ.S103299

Ejemplares similares